Page 263 - metagenics-catalogue_c_en_5
P. 263

Silymax 3





                Product description

                Being pure on the inside is noticed on the outside. Supports the purification
                function of the body. Contains silymarin, a substance from the seed of milk
                thistle, artichoke extract and turmeric (curcuma), which support the
                purification function.


                Ingredients

                 INGREDIENTS PER TABLET
                 Milk thistle seed extract (Silybum marianum) 80% silymarine  150 mg
                 Turmeric extract (Curcuma longa)                            95% tetrahydrocurcuminoids  75

                 mg Artichoke extract (Cynara scolymus) 5% cynarine          60 mg
                 Mixed with: microcrystalline cellulose, maltodextrin, sodium carboxy methyl
                 cellulose, polyvinyl pyrrolidone, hydroxypropyl methyl cellulose, magnesium
                 stearate, silicium dioxide, talc, titanium dioxide, hydroxypropyl
                 cellulose, fractionated coconut oil, tartrazine, sunset yellow


                Packaging


                60 tablets
                Recommended use

                1 tablet daily or as recommended

                Precaution

                Sylibin inhibits the cytochromes P450 3A4 and 2C9, hence prudence is called
                for in patients who take medication which is metabolized via these pathways.






















         Metagenics Europe | info@metagenics.eu | +32(0)59/80.58.24 | www.metagenics.eu      Drawn Up 15/12/2012    Silymax 3    4865
       The information given in this publication is intended explicitly for readers who deal with health and nutrition on professional grounds. In the interest of public health this publication is not intended
       for lay people or consumers. Publisher and authors declare that this publication has been compiled meticulously and to the best of their knowledge. However, they cannot be held responsible for
       the comprehensiveness or potential mistakes of this publication. Publisher and authors do not accept any responsibility for damage, of any kind, resulting from actions and/or decisions based on the
       contents of this publication.
   258   259   260   261   262   263   264   265   266   267   268